Roxane's Oral Morphine Sulfate Gets FDA Approval, But Also Inventory Oversight
This article was originally published in The Pink Sheet Daily
Executive Summary
Boehringer Ingelheim's Roxane Laboratories is the latest beneficiary of FDA's Unapproved Drugs Initiative.